Literature DB >> 14515267

Activation of src-family tyrosine kinases by LPS regulates cytokine production in dendritic cells by controlling AP-1 formation.

Giorgio Napolitani1, Nicola Bortoletto, Luigi Racioppi, Antonio Lanzavecchia, Ugo D'Oro.   

Abstract

The role of src-family tyrosine kinases in LPS-induced DC maturation has not been fully addressed. We show that LPS induces activation of c-Src and Lyn in human DC. Inhibition of these kinasesby PP1 uncoupled LPS-induced cytokine production from the up-regulation of costimulatory molecules, resulting in DC still capable of stimulating T cell proliferation but much less efficient in inducing Th1 differentiation. This is the first example of a pharmacological inhibitor able to modulate the capacity of DC to induce a particular type of immune response. Inhibition of src-family kinases impaired phosphorylation and accumulation of c-Jun, leading to reduced formation of AP-1 complexes upon LPS stimulation. Thus, src-kinases control cytokine production in LPS-induced DC maturation through a timely formation of AP-1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14515267     DOI: 10.1002/eji.200324073

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  23 in total

1.  Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells.

Authors:  Giorgio Napolitani; Andrea Rinaldi; Francesco Bertoni; Federica Sallusto; Antonio Lanzavecchia
Journal:  Nat Immunol       Date:  2005-07-03       Impact factor: 25.606

2.  Relationship between the in vitro response of dendritic cells to Lactobacillus and prevention of tumorigenesis in the mouse.

Authors:  Akimitsu Takagi; Haruo Ikemura; Takeshi Matsuzaki; Mikiko Sato; Koji Nomoto; Masami Morotomi; Teruo Yokokura
Journal:  J Gastroenterol       Date:  2008-09-20       Impact factor: 7.527

3.  Myeloid expression of the AP-1 transcription factor JUNB modulates outcomes of type 1 and type 2 parasitic infections.

Authors:  M F Fontana; A Baccarella; D Kellar; T K Oniskey; P Terinate; S D Rosenberg; E J Huang; D R Herbert; C C Kim
Journal:  Parasite Immunol       Date:  2015-09       Impact factor: 2.280

Review 4.  Regulation of monocyte differentiation by specific signaling modules and associated transcription factor networks.

Authors:  René Huber; Daniel Pietsch; Johannes Günther; Bastian Welz; Nico Vogt; Korbinian Brand
Journal:  Cell Mol Life Sci       Date:  2013-03-24       Impact factor: 9.261

5.  Activation of c-Src: a hub for exogenous pro-oxidant-mediated activation of Toll-like receptor 4 signaling.

Authors:  Rajendra Karki; Yan Zhang; Orisa J Igwe
Journal:  Free Radic Biol Med       Date:  2014-03-15       Impact factor: 7.376

6.  Complement opsonization of HIV-1 results in decreased antiviral and inflammatory responses in immature dendritic cells via CR3.

Authors:  Rada Ellegård; Elisa Crisci; Adam Burgener; Christopher Sjöwall; Kenzie Birse; Garrett Westmacott; Jorma Hinkula; Jeffrey D Lifson; Marie Larsson
Journal:  J Immunol       Date:  2014-09-24       Impact factor: 5.422

7.  Activated apoptotic cells induce dendritic cell maturation via engagement of Toll-like receptor 4 (TLR4), dendritic cell-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin (DC-SIGN), and β2 integrins.

Authors:  Sushil Kumar Pathak; Annette E Sköld; Venkatramanan Mohanram; Catrine Persson; Ulrika Johansson; Anna-Lena Spetz
Journal:  J Biol Chem       Date:  2012-03-06       Impact factor: 5.157

Review 8.  Multiple roles of Lyn kinase in myeloid cell signaling and function.

Authors:  Patrizia Scapini; Shalini Pereira; Hong Zhang; Clifford A Lowell
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

9.  Src kinase participates in LPS-induced activation of NADPH oxidase.

Authors:  Jennifer Check; Christy L Byrd; Jade Menio; Richard A Rippe; Ian N Hines; Michael D Wheeler
Journal:  Mol Immunol       Date:  2009-11-25       Impact factor: 4.407

Review 10.  CaMKK2: a novel target for shaping the androgen-regulated tumor ecosystem.

Authors:  Luigi Racioppi
Journal:  Trends Mol Med       Date:  2013-01-14       Impact factor: 11.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.